Copyright Reports & Markets. All rights reserved.

Global GCLM Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of GCLM Antibody
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global GCLM Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Monoclonal
    • 1.3.3 Polyclonal
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global GCLM Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Immunochemistry (IHC)
    • 1.4.3 Immunofluorescence (IF)
    • 1.4.4 Immunoprecipitation (IP)
    • 1.4.5 Western Blot (WB)
    • 1.4.6 ELISA
    • 1.4.7 Others
  • 1.5 Global GCLM Antibody Market Size & Forecast
    • 1.5.1 Global GCLM Antibody Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global GCLM Antibody Sales Quantity (2018-2029)
    • 1.5.3 Global GCLM Antibody Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck GCLM Antibody Product and Services
    • 2.1.4 Merck GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific GCLM Antibody Product and Services
    • 2.2.4 Thermo Fisher Scientific GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.3 GeneTex
    • 2.3.1 GeneTex Details
    • 2.3.2 GeneTex Major Business
    • 2.3.3 GeneTex GCLM Antibody Product and Services
    • 2.3.4 GeneTex GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 GeneTex Recent Developments/Updates
  • 2.4 Proteintech Group
    • 2.4.1 Proteintech Group Details
    • 2.4.2 Proteintech Group Major Business
    • 2.4.3 Proteintech Group GCLM Antibody Product and Services
    • 2.4.4 Proteintech Group GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Proteintech Group Recent Developments/Updates
  • 2.5 Aviva Systems Biology
    • 2.5.1 Aviva Systems Biology Details
    • 2.5.2 Aviva Systems Biology Major Business
    • 2.5.3 Aviva Systems Biology GCLM Antibody Product and Services
    • 2.5.4 Aviva Systems Biology GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Aviva Systems Biology Recent Developments/Updates
  • 2.6 Novus Biologicals
    • 2.6.1 Novus Biologicals Details
    • 2.6.2 Novus Biologicals Major Business
    • 2.6.3 Novus Biologicals GCLM Antibody Product and Services
    • 2.6.4 Novus Biologicals GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Novus Biologicals Recent Developments/Updates
  • 2.7 LifeSpan BioSciences
    • 2.7.1 LifeSpan BioSciences Details
    • 2.7.2 LifeSpan BioSciences Major Business
    • 2.7.3 LifeSpan BioSciences GCLM Antibody Product and Services
    • 2.7.4 LifeSpan BioSciences GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 LifeSpan BioSciences Recent Developments/Updates
  • 2.8 NSJ Bioreagents
    • 2.8.1 NSJ Bioreagents Details
    • 2.8.2 NSJ Bioreagents Major Business
    • 2.8.3 NSJ Bioreagents GCLM Antibody Product and Services
    • 2.8.4 NSJ Bioreagents GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 NSJ Bioreagents Recent Developments/Updates
  • 2.9 ProSci
    • 2.9.1 ProSci Details
    • 2.9.2 ProSci Major Business
    • 2.9.3 ProSci GCLM Antibody Product and Services
    • 2.9.4 ProSci GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 ProSci Recent Developments/Updates
  • 2.10 RayBiotech
    • 2.10.1 RayBiotech Details
    • 2.10.2 RayBiotech Major Business
    • 2.10.3 RayBiotech GCLM Antibody Product and Services
    • 2.10.4 RayBiotech GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 RayBiotech Recent Developments/Updates
  • 2.11 Abcam
    • 2.11.1 Abcam Details
    • 2.11.2 Abcam Major Business
    • 2.11.3 Abcam GCLM Antibody Product and Services
    • 2.11.4 Abcam GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Abcam Recent Developments/Updates
  • 2.12 OriGene Technologies
    • 2.12.1 OriGene Technologies Details
    • 2.12.2 OriGene Technologies Major Business
    • 2.12.3 OriGene Technologies GCLM Antibody Product and Services
    • 2.12.4 OriGene Technologies GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 OriGene Technologies Recent Developments/Updates
  • 2.13 Leading Biology
    • 2.13.1 Leading Biology Details
    • 2.13.2 Leading Biology Major Business
    • 2.13.3 Leading Biology GCLM Antibody Product and Services
    • 2.13.4 Leading Biology GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Leading Biology Recent Developments/Updates
  • 2.14 ABclonal Technology
    • 2.14.1 ABclonal Technology Details
    • 2.14.2 ABclonal Technology Major Business
    • 2.14.3 ABclonal Technology GCLM Antibody Product and Services
    • 2.14.4 ABclonal Technology GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 ABclonal Technology Recent Developments/Updates
  • 2.15 HUABIO
    • 2.15.1 HUABIO Details
    • 2.15.2 HUABIO Major Business
    • 2.15.3 HUABIO GCLM Antibody Product and Services
    • 2.15.4 HUABIO GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 HUABIO Recent Developments/Updates
  • 2.16 IBL
    • 2.16.1 IBL Details
    • 2.16.2 IBL Major Business
    • 2.16.3 IBL GCLM Antibody Product and Services
    • 2.16.4 IBL GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 IBL Recent Developments/Updates
  • 2.17 St John's Laboratory
    • 2.17.1 St John's Laboratory Details
    • 2.17.2 St John's Laboratory Major Business
    • 2.17.3 St John's Laboratory GCLM Antibody Product and Services
    • 2.17.4 St John's Laboratory GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 St John's Laboratory Recent Developments/Updates
  • 2.18 Sino Biological
    • 2.18.1 Sino Biological Details
    • 2.18.2 Sino Biological Major Business
    • 2.18.3 Sino Biological GCLM Antibody Product and Services
    • 2.18.4 Sino Biological GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Sino Biological Recent Developments/Updates
  • 2.19 AssayPro
    • 2.19.1 AssayPro Details
    • 2.19.2 AssayPro Major Business
    • 2.19.3 AssayPro GCLM Antibody Product and Services
    • 2.19.4 AssayPro GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 AssayPro Recent Developments/Updates
  • 2.20 Biobyt
    • 2.20.1 Biobyt Details
    • 2.20.2 Biobyt Major Business
    • 2.20.3 Biobyt GCLM Antibody Product and Services
    • 2.20.4 Biobyt GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 Biobyt Recent Developments/Updates
  • 2.21 Jingjie PTM BioLab
    • 2.21.1 Jingjie PTM BioLab Details
    • 2.21.2 Jingjie PTM BioLab Major Business
    • 2.21.3 Jingjie PTM BioLab GCLM Antibody Product and Services
    • 2.21.4 Jingjie PTM BioLab GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 Jingjie PTM BioLab Recent Developments/Updates
  • 2.22 Wuhan Fine Biotech
    • 2.22.1 Wuhan Fine Biotech Details
    • 2.22.2 Wuhan Fine Biotech Major Business
    • 2.22.3 Wuhan Fine Biotech GCLM Antibody Product and Services
    • 2.22.4 Wuhan Fine Biotech GCLM Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.22.5 Wuhan Fine Biotech Recent Developments/Updates

3 Competitive Environment: GCLM Antibody by Manufacturer

  • 3.1 Global GCLM Antibody Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global GCLM Antibody Revenue by Manufacturer (2018-2023)
  • 3.3 Global GCLM Antibody Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of GCLM Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 GCLM Antibody Manufacturer Market Share in 2022
    • 3.4.2 Top 6 GCLM Antibody Manufacturer Market Share in 2022
  • 3.5 GCLM Antibody Market: Overall Company Footprint Analysis
    • 3.5.1 GCLM Antibody Market: Region Footprint
    • 3.5.2 GCLM Antibody Market: Company Product Type Footprint
    • 3.5.3 GCLM Antibody Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global GCLM Antibody Market Size by Region
    • 4.1.1 Global GCLM Antibody Sales Quantity by Region (2018-2029)
    • 4.1.2 Global GCLM Antibody Consumption Value by Region (2018-2029)
    • 4.1.3 Global GCLM Antibody Average Price by Region (2018-2029)
  • 4.2 North America GCLM Antibody Consumption Value (2018-2029)
  • 4.3 Europe GCLM Antibody Consumption Value (2018-2029)
  • 4.4 Asia-Pacific GCLM Antibody Consumption Value (2018-2029)
  • 4.5 South America GCLM Antibody Consumption Value (2018-2029)
  • 4.6 Middle East and Africa GCLM Antibody Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global GCLM Antibody Sales Quantity by Type (2018-2029)
  • 5.2 Global GCLM Antibody Consumption Value by Type (2018-2029)
  • 5.3 Global GCLM Antibody Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global GCLM Antibody Sales Quantity by Application (2018-2029)
  • 6.2 Global GCLM Antibody Consumption Value by Application (2018-2029)
  • 6.3 Global GCLM Antibody Average Price by Application (2018-2029)

7 North America

  • 7.1 North America GCLM Antibody Sales Quantity by Type (2018-2029)
  • 7.2 North America GCLM Antibody Sales Quantity by Application (2018-2029)
  • 7.3 North America GCLM Antibody Market Size by Country
    • 7.3.1 North America GCLM Antibody Sales Quantity by Country (2018-2029)
    • 7.3.2 North America GCLM Antibody Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe GCLM Antibody Sales Quantity by Type (2018-2029)
  • 8.2 Europe GCLM Antibody Sales Quantity by Application (2018-2029)
  • 8.3 Europe GCLM Antibody Market Size by Country
    • 8.3.1 Europe GCLM Antibody Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe GCLM Antibody Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific GCLM Antibody Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific GCLM Antibody Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific GCLM Antibody Market Size by Region
    • 9.3.1 Asia-Pacific GCLM Antibody Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific GCLM Antibody Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America GCLM Antibody Sales Quantity by Type (2018-2029)
  • 10.2 South America GCLM Antibody Sales Quantity by Application (2018-2029)
  • 10.3 South America GCLM Antibody Market Size by Country
    • 10.3.1 South America GCLM Antibody Sales Quantity by Country (2018-2029)
    • 10.3.2 South America GCLM Antibody Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa GCLM Antibody Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa GCLM Antibody Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa GCLM Antibody Market Size by Country
    • 11.3.1 Middle East & Africa GCLM Antibody Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa GCLM Antibody Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 GCLM Antibody Market Drivers
  • 12.2 GCLM Antibody Market Restraints
  • 12.3 GCLM Antibody Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of GCLM Antibody and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of GCLM Antibody
  • 13.3 GCLM Antibody Production Process
  • 13.4 GCLM Antibody Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 GCLM Antibody Typical Distributors
  • 14.3 GCLM Antibody Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global GCLM Antibody market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Growing patient base, launch of GCLM antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in GCLM antibody market revenue.
    Glutamate-cysteine ligase (GCLM) is the first rate limiting enzyme of glutathione synthesis.
    This report is a detailed and comprehensive analysis for global GCLM Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global GCLM Antibody market size and forecasts, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
    Global GCLM Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
    Global GCLM Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
    Global GCLM Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (ml), and ASP (US$/ml), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for GCLM Antibody
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global GCLM Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Thermo Fisher Scientific, GeneTex, Proteintech Group and Aviva Systems Biology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    GCLM Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Monoclonal
    Polyclonal
    Market segment by Application
    Immunochemistry (IHC)
    Immunofluorescence (IF)
    Immunoprecipitation (IP)
    Western Blot (WB)
    ELISA
    Others
    Major players covered
    Merck
    Thermo Fisher Scientific
    GeneTex
    Proteintech Group
    Aviva Systems Biology
    Novus Biologicals
    LifeSpan BioSciences
    NSJ Bioreagents
    ProSci
    RayBiotech
    Abcam
    OriGene Technologies
    Leading Biology
    ABclonal Technology
    HUABIO
    IBL
    St John's Laboratory
    Sino Biological
    AssayPro
    Biobyt
    Jingjie PTM BioLab
    Wuhan Fine Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe GCLM Antibody product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of GCLM Antibody, with price, sales, revenue and global market share of GCLM Antibody from 2018 to 2023.
    Chapter 3, the GCLM Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the GCLM Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and GCLM Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of GCLM Antibody.
    Chapter 14 and 15, to describe GCLM Antibody sales channel, distributors, customers, research findings and conclusion.

    Buy now